论文部分内容阅读
腹膜炎为不卧床持续性腹膜透析(CAPD)的主要并发症,多数发作能处理成功而不必中断腹膜透析。但感染可引起腹膜改变或因形成粘连失去腹膜腔,导致暂时或永久性透析中断。感染偶尔也可致命。 CAPD腹膜炎的实验室诊断方法和细菌分离还在逐步发展。抗生素的选择、剂量、给药途径、给药时间长短仍缺乏一致的意见。因此,英国抗菌化疗协会成立了一个工作队,制定标准以指导CAPD相关性腹膜炎的诊断和处理。
Peritonitis is a major complication of ambulatory continuous peritoneal dialysis (CAPD) and most episodes can be successfully treated without disruption of peritoneal dialysis. However, infection can cause peritoneal changes or loss of peritoneal cavity due to adhesions, resulting in temporary or permanent dialysis interruptions. Inflammation can be fatal occasionally. Laboratory diagnosis of CAPD peritonitis and bacterial isolation are still evolving. The choice of antibiotics, dosage, route of administration, the length of administration is still a lack of consensus. Therefore, the British Antibacterial Chemotherapy Association set up a task force to develop standards to guide the diagnosis and treatment of CAPD-related peritonitis.